Choosing the best form of Risperidone for you
Part of Brain & nervous system, Mental health clinical trials.
This study asks patients with certain mental health conditions or their caregivers which form of Risperidone they like better. Your preferences can help doctors understand what works best for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have schizophrenia, bipolar disorder, autism, or intellectual disability, or you are the main caregiver for someone who does.
- You can read and understand Chinese.
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at long-acting (extended-release) antipsychotic medicine options in people with schizophrenia, compared with regular tablets. You may be able to join if you were already part of a related earlier study or its real-world follow-up.
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
This study tests how well a new aripiprazole injection works in your body compared to a standard version. You'll receive injections while your schizophrenia symptoms are stable, and researchers will measure drug levels in your blood to ensure the new version works the same way.
This study tests a “shared decision-making” approach to help you and your clinic choose how to use antipsychotic medicines. It may help you feel more involved in decisions if you’re currently taking an antipsychotic, recently stopped, or are thinking about stopping.
This trial tests a medication called paliperidone for adults with schizophrenia. If you have been diagnosed for at least 3 months and haven't had success with one antipsychotic or haven't taken any yet, this study might help find a treatment that works better for you.
This trial tests if the drug pimavanserin can help reduce rigid or repetitive behaviors in people with autism spectrum disorder. It may be an option if you or your child struggle with these symptoms and want to try a new treatment.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.